| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/16/1991 | EP0366777A4 Stimulation of chemotaxis by chemotactic peptides |
| 01/16/1991 | CN1011243B Regulatory site of expression for heterogenetic gene in yeast |
| 01/16/1991 | CA2021147A1 Process for preparing and purifying an anticoagulant |
| 01/15/1991 | WO1991001333A1 Methods of treating or preventing autoimmune uveoretinitis in mammals |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | WO1991001146A1 Cytokine and hormone carriers for conjugate vaccines |
| 01/15/1991 | US4985544 Process for renaturing fish growth hormone |
| 01/15/1991 | US4985543 Lectins and antiretroviral drugs containing the lectins as active ingredient |
| 01/15/1991 | US4985407 Renin Inhibitors, Treating Cardiovascular Disorders, Hypotensive Agents |
| 01/15/1991 | US4985406 Central nervous system disorders, dopaminergic pathways |
| 01/15/1991 | US4985356 Cloning of DNA encoding human motilin precursor and expression of the precursor |
| 01/15/1991 | US4985352 DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof |
| 01/15/1991 | US4985144 Purification of protein antigens |
| 01/15/1991 | CA2063271A1 Cytokine and hormone carriers for conjugate vaccines |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | CA2020461A1 Process for the production of hydrolyzed vegetable proteins and the product therefrom |
| 01/14/1991 | WO1991000909A1 Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
| 01/14/1991 | CA2036384A1 Modified transforming growth factor ó oligopeptides and pharmaceutical compositions thereof |
| 01/14/1991 | CA2020720A1 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/13/1991 | CA2020740A1 Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines |
| 01/12/1991 | WO1991000911A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2063389A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2020828A1 Streptokinase proteins, corresponding genes, corresponding plasmid recombinants, corresponding transformants and processes for preparing same |
| 01/12/1991 | CA2019893A1 Method of fractionating plasma protein |
| 01/11/1991 | WO1991000870A1 Somatotropin analogs |
| 01/11/1991 | CA2057035A1 Somatotropin analogs |
| 01/11/1991 | CA2020768A1 Compounds from biopolymers and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
| 01/10/1991 | WO1991000360A1 Bispecific reagents for aids therapy |
| 01/10/1991 | WO1991000357A1 New strain with filamentous fungi mutants, process for the production of recombinant proteins using said strain, and strains and proteins produced by said process |
| 01/10/1991 | WO1991000355A1 Genetic elements useful in production of active protein |
| 01/10/1991 | WO1991000352A1 Pestivirus nucleotide sequences and polypeptides |
| 01/10/1991 | WO1991000351A1 Fungal stress proteins |
| 01/10/1991 | WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
| 01/10/1991 | WO1991000347A1 Method of producing proteins with fviii activity and/or fviii derivatives |
| 01/10/1991 | WO1991000341A1 Sparged insect cell culture and the expression of recombinant proteins therein |
| 01/10/1991 | WO1991000340A1 Antibody to p. falciparum antigen and hybridoma for making same |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000294A1 Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000291A1 Serpin variants |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1991000046A2 Method and apparatus for preparing fibrinogen adhesive from whole blood |
| 01/10/1991 | WO1991000045A1 Reagents for detecting siv and hiv-2 |
| 01/10/1991 | WO1990014427A3 Multivalent repressor of gene function |
| 01/10/1991 | WO1990014069A3 Keratinocyte autocrine factor |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/10/1991 | WO1990012874A3 Cysteine added variants of polypeptides and chemical modifications thereof |
| 01/10/1991 | WO1990012807A3 Purified, highly specific antibodies against gene products including retinoblastoma and method |
| 01/10/1991 | DE3921644A1 New peptide(s) with immunological activity - used in treatment of acute or chronic infections, inflammatory processes and auto:immune diseases |
| 01/10/1991 | CA2062795A1 Bispecific reagents for aids therapy |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407259A1 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, preparation and method and application therefor |
| 01/09/1991 | EP0407230A1 Sporozoite and liver-stage protein antigen of P. falciparum |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0407092A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same |
| 01/09/1991 | EP0407008A2 Fibronectin fragment |
| 01/09/1991 | EP0406913A1 Microbial expression of insulin-like growth factor |
| 01/09/1991 | EP0406880A2 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/09/1991 | EP0406857A1 Proteins and production thereof |
| 01/09/1991 | EP0406856A2 Stabilized FGF composition and production thereof |
| 01/09/1991 | EP0406850A1 Process for obtaining purple membranes containing bacteriorhodopsin |
| 01/09/1991 | EP0406738A2 Production of acidic FGF protein |
| 01/09/1991 | EP0406732A2 Highly concentrated and low-viscosity surfactant suspension |
| 01/09/1991 | EP0406725A1 Cyclic tetrapeptide and process for preparing the same |
| 01/09/1991 | EP0406557A2 Multivalent repressor of gene function |
| 01/09/1991 | EP0406545A2 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 01/09/1991 | EP0406542A1 A method for detecting precancerous and cancerous cervical intraepithelium |
| 01/09/1991 | EP0406511A1 Cloning of non A non B hepatitis virus gene and expression thereof |
| 01/09/1991 | EP0406473A1 Ion capture reagents and methods for performing binding assays |
| 01/09/1991 | EP0406428A1 Peptide derivatives and their use |
| 01/09/1991 | EP0406402A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 01/09/1991 | EP0406385A1 Separation of antigens with a second antibody specific for the kappa chain of a first antibody |
| 01/09/1991 | EP0406367A1 Scavenger receptor protein and antibody thereto |
| 01/09/1991 | EP0406363A1 Method to diagnose amyloidoses specifically and substance therefor. |
| 01/09/1991 | EP0406357A1 Functional recombinantly prepared synthetic protein polymer |
| 01/09/1991 | EP0406305A1 Methods and compositions incorporating autoimmune antigenic epitopes |
| 01/09/1991 | EP0406303A1 Assay for human immunodeficiency virus. |
| 01/09/1991 | EP0406286A1 Dna encoding a ryegrass pollen allergen |
| 01/09/1991 | EP0406267A1 Non-nuclear chromosomal transformation |
| 01/09/1991 | EP0406259A1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours. |
| 01/09/1991 | EP0406257A1 Proteins which induce immunological effector cell activation and chemattraction |
| 01/09/1991 | EP0197062B1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens |
| 01/08/1991 | WO1991000908A1 Dna encoding a lipase and a lipase modulator |
| 01/08/1991 | WO1990010058A2 Method for production and purification of hepatitis b vaccine |
| 01/08/1991 | US4983722 Exposure to anion exchange material, adsorption, elution |
| 01/08/1991 | US4983721 Solvents for collagen |
| 01/08/1991 | US4983520 DNA sequence encoding modified hepatitis B virus surface antigen P31 protein |
| 01/08/1991 | US4983519 Genetic engineering |
| 01/08/1991 | US4983518 Eukaryotic expression vectors with multimeric enhancer segments, a process for the preparation thereof and the use thereof |
| 01/08/1991 | US4983387 Antibody producing polypeptide |
| 01/08/1991 | CA2063590A1 Dna encoding a lipase and a lipase modulator |
| 01/08/1991 | CA2020654A1 Stabilized fgf composition and production thereof |
| 01/08/1991 | CA2020650A1 Technique for rapid peptide coupling |
| 01/08/1991 | CA2020593A1 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/07/1991 | WO1991001004A1 Hybrid molecules |
| 01/07/1991 | WO1991000736A1 Dynorphin analogs specific for kappa opioid receptors |
| 01/07/1991 | CA2063712A1 Dynorphin analogs specific for kappa opioid receptors |